SCHEMBL19607342

SCHEMBL19607342

Cc1c[n+](-c2ccccc2C)ccc1-c1cc[n+](C)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC22A2 O15244 1/20 0.41
▸ SLC22A1 O15245 1/20 0.41
▸ SLC22A3 O75751 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ ACHE P22303 1/20 0.40
▸ RAB9A P51151 2/20 0.35
▸ APOBEC3A P31941 2/20 0.35
▸ APOBEC3G Q9HC16 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ NPC1 O15118 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ QDPR P09417 2/20 0.32
▸ CHAT P28329 2/20 0.31
▸ IDO1 P14902 1/20 0.31
▸ PABPC1 P11940 1/20 0.31
▸ EIF4H Q15056 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19601082 0.92 ACHE (0.43) ACHERAB9ANPC1CA12CA1
SCHEMBL5157528 0.83 SLC22A2 (0.56) SLC22A2SLC22A1SLC22A3SLC6A4ACHE
SCHEMBL19601088 0.81 ACHE (0.54) ACHECA12CA1CA2CA9
SCHEMBL21202121 0.80 CHAT (0.38) SLC22A2SLC22A1SLC22A3SLC6A4ACHE
SCHEMBL19601139 0.80 ACHE (0.36) ACHE
SCHEMBL19601135 0.79 ESR2 (0.36) SLC22A2SLC22A1SLC22A3SLC6A4ACHE
SCHEMBL19607333 0.77 SLC6A4 (0.44) SLC22A2SLC22A1SLC22A3SLC6A4APOBEC3A
SCHEMBL19601079 0.76 ACHE (0.40) ACHERAB9ANPC1CA12CA1
SCHEMBL19607338 0.75 ACHE (0.39) SLC22A2SLC22A1SLC22A3SLC6A4ACHE
SCHEMBL19607241 0.75 ACHE (0.48) ACHECA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10310350-B2 Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same CANON KABUSHIKI KAISHA (JP) 2019-06-04 — — US disclosed
US-20170329195-A1 ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME CANON KABUSHIKI KAISHA (JP) 2017-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10310350-B2 Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same KCNJ2, KCNH3, KCNN2 SLC22A2 693/4885SLC22A1 760/4885SLC22A3 926/4885
US-20170329195-A1 ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME KCNJ2, KCNH3, KCNN2 SLC22A2 693/4885SLC22A1 760/4885SLC22A3 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback